Arcus Biosciences Inc

Arcus insider selling: CEO Terry Rosen’s recent “charitable gift” stock sale signals cautious portfolio shifts and impacts investor sentiment on the biotech’s future.

Arcus Biosciences insider selling reveals a cautious exit strategy, dampening investor confidence amid a negative P/E and high burn rate.